Tuesday, February 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Intel Secures $3.3 Billion Deal in Strategic Restructuring Move

Robert Sasse by Robert Sasse
September 17, 2025
in Mergers & Acquisitions, Semiconductors, Tech & Software, Turnaround
0
Intel Stock
0
SHARES
132
VIEWS
Share on FacebookShare on Twitter

Intel has executed a significant transaction within its broader turnaround strategy, a move welcomed by investors. The semiconductor giant, which has faced considerable challenges, finalized the sale of a majority stake in its Altera unit for $3.3 billion. Concurrently, the company revised its operational cost forecast downward, signaling a renewed focus on financial discipline. The central question remains whether this strategic divestiture can truly catalyze a sustained recovery for the chipmaker.

A Pivotal Transaction for the Chipmaker

On September 12, Intel completed the sale of a 51% interest in its programmable chip division, Altera, to the private equity firm Silver Lake. This transaction stands in stark contrast to the unit’s original acquisition cost; Intel purchased Altera in 2015 for nearly $17 billion. The deal values the majority stake at a fraction of that initial investment, though Intel will retain a 49% minority shareholding.

The immediate financial impact is constructive. Intel has lowered its projected operating expenses for 2025 to $16.8 billion, down from a previous forecast of $17 billion. Furthermore, Altera will no longer be fully consolidated on Intel’s balance sheet from the closing date, providing a measure of financial relief.

Should investors sell immediately? Or is it worth buying Intel?

Leadership’s Radical Refocusing Strategy

This sale is a cornerstone of the sweeping restructuring plan led by CEO Lip-Bu Tan, who is guiding Intel through one of its most complex periods. The overarching strategy involves a sharpened focus on core growth areas, specifically its foundry services and AI chip segments, to better compete with industry leaders like TSMC.

Key Deal Metrics:
– Transaction Value: $3.3 billion for a 51% stake
– Altera H1 2025 Revenue: $816 million
– Altera Gross Margin: 55%
– Intel’s Retained Stake: 49%

Market Response and the Road Ahead

Investor reaction to the announcement was positive, with Intel’s stock advancing approximately one percent. However, the true test of this strategic shift is yet to come. The company must now demonstrate that its intensified focus on foundry operations and artificial intelligence technologies will yield tangible results. Upcoming quarterly earnings reports will provide the first clear look at Intel’s operational performance following the deconsolidation of Altera, offering a more precise picture of its core business strength.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from February 3 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.

Intel: Buy or sell? Read more here...

Tags: Intel
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Xiaomi Stock
Analysis

Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads

February 3, 2026
Apple Stock
Earnings

Apple Shares Surge on Stellar Quarterly Performance

February 3, 2026
Micron Stock
AI & Quantum Computing

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

February 2, 2026
Next Post
Pepsi Stock

Activist Investor Elliott Takes $4 Billion Stake in PepsiCo, Demands Strategic Overhaul

Oracle Stock

Oracle Stock Surges on Potential TikTok Partnership Breakthrough

Salesforce Stock

Salesforce Faces Dual Pressures: Insider Selling and FBI Cyberattack Warning

Recommended

Biotechnology Markets and money

Ginkgo Bioworks Acquires Reverie Labs Assets in Groundbreaking Biotech and AI Integration Deal

2 years ago
Salesforce Stock

Salesforce’s Defining Moment Approaches as Quarterly Results Loom

2 months ago
Applovin Stock

Applovin Stock: Institutional Buying Clashes With Major Insider Selling

5 months ago
Technology Quantum computing Market Capitalization

The Importance of Innovation for Business Growth and Value Generation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Barrick Gold Investors Brace for a Pivotal Week

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

Uranium Energy’s Strategic Position Strengthens Amid US Nuclear Push

Regulatory Showdown in Washington Weighs on Coinbase Shares

Fintechwerx Advances AI Integration with New Platform Development

Realty Income Charts a New Course with Strategic GIC Alliance

Trending

Unitedhealth Stock
Earnings

UnitedHealth Faces Investor Backlash Over Regulatory Proposal

by Felix Baarz
February 3, 2026
0

Shares of UnitedHealth Group came under significant pressure this week following a regulatory announcement that fell dramatically...

Xiaomi Stock

Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads

February 3, 2026
Apple Stock

Apple Shares Surge on Stellar Quarterly Performance

February 3, 2026
Barrick Stock

Barrick Gold Investors Brace for a Pivotal Week

February 3, 2026
Micron Stock

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

February 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Faces Investor Backlash Over Regulatory Proposal
  • Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads
  • Apple Shares Surge on Stellar Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com